APH vs ERNA
Amphenol Corporation (APH) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
APH currently screens at market cap $170.77B and trailing P/E 39.9. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the APH and ERNA stock pages for the full models.
Not investment advice.